Deletion of Ptpn1 induces myeloproliferative neoplasm.
作者信息
Jobe F, Patel B, Kuzmanovic T, Makishima H, Yang Y, Przychodzen B, Hutchison R E, Bence K K, Maciejewski J P, Mohi G
机构信息
Department of Pharmacology, SUNY Upstate Medical University, Syracuse, NY, USA.
Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA.
出版信息
Leukemia. 2017 May;31(5):1229-1234. doi: 10.1038/leu.2017.31. Epub 2017 Jan 23.
Abstract
摘要
相似文献
1
Deletion of Ptpn1 induces myeloproliferative neoplasm.Ptpn1基因的缺失会诱发骨髓增殖性肿瘤。
Leukemia. 2017 May;31(5):1229-1234. doi: 10.1038/leu.2017.31. Epub 2017 Jan 23.
2
7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe.髓系恶性肿瘤中的7q22缺失：需留意荧光原位杂交（FISH）探针的设计。
Ann Biol Clin (Paris). 2019 Apr 1;77(2):229-230. doi: 10.1684/abc.2019.1425.
3
Prognostic significance of del(20q) in patients with hematological malignancies.血液系统恶性肿瘤患者中20号染色体长臂缺失（del(20q)）的预后意义
Cancer Genet Cytogenet. 2005 Jul 15;160(2):188-92. doi: 10.1016/j.cancergencyto.2004.12.019.
4
Chromosome 20 deletions in myelodysplastic syndromes and Philadelphia-chromosome-negative myeloproliferative disorders: characterization by molecular cytogenetics of commonly deleted and retained regions.骨髓增生异常综合征和费城染色体阴性骨髓增殖性疾病中的20号染色体缺失：常见缺失和保留区域的分子细胞遗传学特征分析
Ann Hematol. 2008 Jul;87(7):537-44. doi: 10.1007/s00277-008-0462-3. Epub 2008 Mar 19.
5
Genomic analysis of clonal eosinophils by CGH arrays reveals new genetic regions involved in chronic eosinophilia.通过比较基因组杂交阵列对克隆性嗜酸性粒细胞进行基因组分析，揭示了与慢性嗜酸性粒细胞增多相关的新基因区域。
Eur J Haematol. 2014 Nov;93(5):422-8. doi: 10.1111/ejh.12379. Epub 2014 Jun 26.
6
Issue Highlights - July 2019.
Cytometry B Clin Cytom. 2019 Jul;96(4):253-255. doi: 10.1002/cyto.b.21836.
7
Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution.8p11.2 染色体易位：在单机构连续队列的 13 例病例中，FGFR1 和 MYST3 的 FISH 分析及其与临床病理的相关性。
Am J Hematol. 2010 Apr;85(4):238-42. doi: 10.1002/ajh.21631.
8
The myeloproliferative neoplasms: insights into molecular pathogenesis and changes in WHO classification and criteria for diagnosis.骨髓增殖性肿瘤：对分子发病机制的见解以及世界卫生组织分类和诊断标准的变化
Hematol Oncol Clin North Am. 2009 Aug;23(4):693-708. doi: 10.1016/j.hoc.2009.04.002.
9
Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling.Jak2V617F驱动的骨髓增殖性肿瘤独立于白细胞介素-3受体β共同信号传导而发生。
Haematologica. 2016 Mar;101(3):e77-80. doi: 10.3324/haematol.2015.136705. Epub 2015 Nov 20.
10
Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.骨髓增殖性疾病患者中涉及失活X染色体的易位（X；20）。
Cancer Genet Cytogenet. 2005 Apr 1;158(1):81-3. doi: 10.1016/j.cancergencyto.2004.08.029.
引用本文的文献
1
Protein tyrosine phosphatase 1B in metabolic diseases and drug development.蛋白酪氨酸磷酸酶 1B 在代谢性疾病和药物研发中的作用。
Nat Rev Endocrinol. 2024 Jun;20(6):366-378. doi: 10.1038/s41574-024-00965-1. Epub 2024 Mar 22.
2
Protein tyrosine phosphatase PTPL1 suppresses lung cancer through Src/ERK/YAP1 signaling.蛋白酪氨酸磷酸酶 PTPL1 通过Src/ERK/YAP1 信号通路抑制肺癌。
Thorac Cancer. 2022 Nov;13(21):3042-3051. doi: 10.1111/1759-7714.14657. Epub 2022 Oct 4.
3
Biochemical, Enzymatic, and Computational Characterization of Recurrent Somatic Mutations of the Human Protein Tyrosine Phosphatase PTP1B in Primary Mediastinal B Cell Lymphoma.原发性纵隔 B 细胞淋巴瘤中人类蛋白酪氨酸磷酸酶 PTP1B 反复出现的体细胞突变的生化、酶学和计算特征。
Int J Mol Sci. 2022 Jun 24;23(13):7060. doi: 10.3390/ijms23137060.
4
Hippo kinase loss contributes to del(20q) hematologic malignancies through chronic innate immune activation.Hippo 激酶缺失通过慢性固有免疫激活导致 del(20q) 血液系统恶性肿瘤。
Blood. 2019 Nov 14;134(20):1730-1744. doi: 10.1182/blood.2019000170.
5
Deficiency in Protein Tyrosine Phosphatase PTP1B Shortens Lifespan and Leads to Development of Acute Leukemia.蛋白酪氨酸磷酸酶 PTP1B 缺乏会缩短寿命并导致急性白血病的发生。
Cancer Res. 2018 Jan 1;78(1):75-87. doi: 10.1158/0008-5472.CAN-17-0946. Epub 2017 Nov 9.
本文引用的文献
1
A compendium of cytogenetic abnormalities in myelofibrosis: molecular and phenotypic correlates in 826 patients.骨髓纤维化细胞遗传学异常简编：826例患者的分子与表型相关性
Br J Haematol. 2015 Apr;169(1):71-6. doi: 10.1111/bjh.13260. Epub 2014 Dec 17.
2
Combined MEK and JAK inhibition abrogates murine myeloproliferative neoplasm.MEK 和 JAK 联合抑制消除了小鼠骨髓增生性肿瘤。
J Clin Invest. 2014 Jun;124(6):2762-73. doi: 10.1172/JCI74182. Epub 2014 May 8.
3
Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma.原发性纵隔 B 细胞淋巴瘤和霍奇金淋巴瘤中 PTPN1 的反复体细胞突变。
Nat Genet. 2014 Apr;46(4):329-35. doi: 10.1038/ng.2900. Epub 2014 Feb 16.
4
MYBL2 is a sub-haploinsufficient tumor suppressor gene in myeloid malignancy.MYBL2是髓系恶性肿瘤中的一个亚单倍体不足的肿瘤抑制基因。
Elife. 2013 Jul 16;2:e00825. doi: 10.7554/eLife.00825.
5
AKT is a therapeutic target in myeloproliferative neoplasms.AKT 是骨髓增殖性肿瘤的治疗靶点。
Leukemia. 2013 Sep;27(9):1882-90. doi: 10.1038/leu.2013.167. Epub 2013 Jun 10.
6
Cooperativity of imprinted genes inactivated by acquired chromosome 20q deletions.被获得性 20q 染色体缺失失活的印迹基因的协同性。
J Clin Invest. 2013 May;123(5):2169-82. doi: 10.1172/JCI66113. Epub 2013 Apr 1.
7
Critical requirement for Stat5 in a mouse model of polycythemia vera.Stat5 在小鼠真性红细胞增多症模型中的关键要求。
Blood. 2012 Apr 12;119(15):3539-49. doi: 10.1182/blood-2011-03-345215. Epub 2011 Dec 5.
8
Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis.应用全基因组单核苷酸多态性微阵列分析对髓系恶性肿瘤 20q 染色体臂异常进行特征分析。
Genes Chromosomes Cancer. 2010 Apr;49(4):390-9. doi: 10.1002/gcc.20748.
9
Myeloproliferative disorders.骨髓增殖性疾病
Blood. 2008 Sep 15;112(6):2190-8. doi: 10.1182/blood-2008-03-077966.
10
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.蛋白酪氨酸磷酸酶1B缺乏或抑制可延缓ErbB2诱导的乳腺肿瘤发生，并预防肺转移。
Nat Genet. 2007 Mar;39(3):338-46. doi: 10.1038/ng1963. Epub 2007 Jan 28.
Zotero 插件